| Reconciliation Of Income Tax Expense (Benefit) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended
|
|
Six Months Ended
|
|
|
March 31,
|
|
March 31,
|
|
|
2018
|
|
2017
|
|
2018
|
|
2017
|
|
Income tax benefit at statutory rates
|
$
|
(1,077,736)
|
|
$
|
(884,000)
|
|
$
|
(3,628,736)
|
|
$
|
(1,529,000)
|
|
Effect of change in U.S. tax rate
|
|
—
|
|
|
—
|
|
|
(187,000)
|
|
|
—
|
|
State income tax benefit, net of federal benefits
|
|
(385,395)
|
|
|
(133,000)
|
|
|
(948,395)
|
|
|
(229,000)
|
|
Non-deductible business acquisition expenses
|
|
—
|
|
|
42,000
|
|
|
—
|
|
|
153,000
|
|
Non-deductible expenses - other
|
|
8,702
|
|
|
3,000
|
|
|
12,702
|
|
|
4,000
|
|
Effect of lower foreign income tax rates
|
|
50,981
|
|
|
120,641
|
|
|
80,386
|
|
|
202,377
|
|
Other
|
|
101,032
|
|
|
27,326
|
|
|
122,574
|
|
|
44,521
|
|
Income tax benefit
|
$
|
(1,302,416)
|
|
$
|
(824,033)
|
|
$
|
(4,548,469)
|
|
$
|
(1,354,102)
|
|
| Significant Components Of Deferred Tax Assets And Liabilities |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
March 31,
|
|
September 30,
|
|
Deferred tax assets:
|
2018
|
|
2017
|
|
Federal net operating loss carryforwards
|
$
|
4,922,000
|
|
$
|
4,075,000
|
|
State net operating loss carryforwards
|
|
2,002,000
|
|
|
963,000
|
|
AMT credit carryforward
|
|
533,000
|
|
|
533,000
|
|
Foreign net operating loss carryforwards – U.K.
|
|
10,685,000
|
|
|
10,578,000
|
|
Foreign capital allowance – U.K.
|
|
108,000
|
|
|
108,000
|
|
U.K. bad debts
|
|
2,000
|
|
|
2,000
|
|
Restricted stock – U.K.
|
|
1,000
|
|
|
1,000
|
|
U.S. unearned revenue
|
|
249,000
|
|
|
409,000
|
|
U.S. deferred rent
|
|
23,000
|
|
|
76,000
|
|
Share-based compensation
|
|
456,000
|
|
|
447,000
|
|
Foreign tax credits
|
|
1,797,000
|
|
|
1,797,000
|
|
Other, net - U.S.
|
|
77,000
|
|
|
82,000
|
|
Gross deferred tax assets
|
|
20,855,000
|
|
|
19,071,000
|
|
Valuation allowance for deferred tax assets
|
|
(2,144,000)
|
|
|
(2,144,000)
|
|
Net deferred tax assets
|
|
18,711,000
|
|
|
16,927,000
|
|
Deferred tax liabilities:
|
|
|
|
|
|
|
In process research and development
|
|
(4,562,000)
|
|
|
(7,000,000)
|
|
Developed technology
|
|
(562,000)
|
|
|
(900,000)
|
|
Covenant not-to-compete
|
|
(101,000)
|
|
|
(200,000)
|
|
Other
|
|
(5,442)
|
|
|
—
|
|
Net deferred tax liabilities
|
|
(5,230,442)
|
|
|
(8,100,000)
|
|
Net deferred tax asset
|
$
|
13,480,558
|
|
$
|
8,827,000
|
|
| Schedule Of Deferred Tax Amounts Classified In Balance Sheets |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
March 31,
|
|
September 30,
|
|
|
2018
|
|
2017
|
|
Long-term deferred tax asset - U.S.
|
$
|
4,829,377
|
|
$
|
282,000
|
|
Long-term deferred tax asset - U.K.
|
|
8,651,181
|
|
|
8,545,000
|
|
Total long-term deferred tax asset
|
$
|
13,480,558
|
|
$
|
8,827,000
|
|